Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
48,809,163
-
Total 13F shares
-
32,503,442
-
Share change
-
+6,054,002
-
Total reported value
-
$318,897,469
-
Put/Call ratio
-
35%
-
Price per share
-
$9.82
-
Number of holders
-
159
-
Value change
-
+$61,080,938
-
Number of buys
-
75
-
Number of sells
-
58
Institutional Holders of Ginkgo Bioworks Holdings, Inc. - Class A Common Stock (DNA) as of Q4 2024
As of 31 Dec 2024,
Ginkgo Bioworks Holdings, Inc. - Class A Common Stock (DNA) was held by
159 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,503,442 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, VIKING GLOBAL INVESTORS LP, BAILLIE GIFFORD & CO, VANGUARD GROUP INC, Anchorage Capital Group, L.L.C., EcoR1 Capital, LLC, BlackRock, Inc., Opaleye Management Inc., Legal & General Group Plc, and TWO SIGMA ADVISERS, LP.
This page lists
159
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.